You have 9 free searches left this month | for more free features.

tiragolumab

Showing 1 - 22 of 22

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Stage II Melanoma Trial in United States (Atezolizumab, Tiragolumab, Signatera Assay)

Not yet recruiting
  • Stage II Melanoma
  • Duarte, California
  • +5 more
Jun 6, 2022

Cohort 1 : Metastatic Non Small Cell Lung Cancer, Cohort 2 : Metastatic Bladder Cancer, Cohort 3 : Metastatic Renal Cell

Not yet recruiting
  • Cohort 1 : Metastatic Non Small Cell Lung Cancer
  • +3 more
  • Atezolizumab 60 MG/1 ML Intravenous Solution [TECENTRIQ]
  • +2 more
  • Dijon, Bourgogne, France
    Centre Georges Fran├žois Leclerc (CGFL)
Feb 18, 2022

NSCLC, Solid Tumor Trial in United States (Atezolizumab, Chemotherapy (Arm A Only), Tiragolumab)

Recruiting
  • Non-Small Cell Lung Cancer
  • Solid Tumor
  • Fort Myers, Florida
  • +6 more
Feb 16, 2022

Small Cell Lung Carcinoma Trial in China (Tiragolumab, Atezolizumab, Carboplatin)

Active, not recruiting
  • Small Cell Lung Carcinoma
  • Tiragolumab
  • +4 more
  • Beijing, China
  • +15 more
Aug 15, 2022

Stomach Tumors, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (Atezolizumab, Tiragolumab, Oxaliplatin)

Active, not recruiting
  • Stomach Neoplasms
  • +2 more
  • Beijing, China
  • +10 more
Jul 15, 2022

Metastatic Malignancy Trial in Houston (Atezolizumab, Tiragolumab)

Not yet recruiting
  • Metastatic Malignancy
  • Houston, Texas
    M D Anderson Cancer Center
May 26, 2022

Non-Hodgkin Lymphoma, Follicular Lymphoma Trial in Worldwide (Mosunetuzumab SC, Tiragolumab, Atezolizumab)

Recruiting
  • Non-Hodgkin Lymphoma, Follicular Lymphoma
  • Mosunetuzumab SC
  • +3 more
  • Ann Arbor, Michigan
  • +14 more
Aug 12, 2022

Carcinoma, Small Cell Lung Trial in China (Atezolizumab, Tiragolumab, Placebo)

Recruiting
  • Carcinoma, Small Cell Lung
  • Beijing City, China
  • +21 more
Aug 17, 2022

NSCLC (NSCLC) Trial in Worldwide (Atezolizumab, Tiragolumab, Carboplatin)

Recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • Duarte, California
  • +23 more
Aug 8, 2022

Advanced/Metastatic Tumors Trial in Worldwide (Atezolizumab, Tiragolumab, Carboplatin)

Recruiting
  • Advanced/Metastatic Tumors
  • Scottsdale, Arizona
  • +32 more
Aug 8, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage IIIA Cutaneous

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +5 more
  • Jacksonville, Florida
  • +2 more
Mar 4, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in Duarte, Portland (Atezolizumab, Tiragolumab, Immune-modulating

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Duarte, California
  • +1 more
Aug 16, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Worldwide (Atezolizumab, Tiragolumab, Placebo)

Active, not recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • La Jolla, California
  • +57 more
May 18, 2022

NSCLC (NSCLC) Trial in Worldwide (Tiragolumab, Atezolizumab, Pemetrexed)

Recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • Tiragolumab
  • +6 more
  • Jonesboro, Arkansas
  • +92 more
Jul 29, 2022

Gastric and Gastroesophageal Junction Carcinoma Trial in China (Atezolizumab, Capecitabine, Oxaliplatin)

Recruiting
  • Gastric and Gastroesophageal Junction Carcinoma
  • Beijing City, China
  • +11 more
Jul 29, 2022

Melanoma Trial in Worldwide (Nivolumab, Ipilimumab, RO7247669)

Recruiting
  • Melanoma
  • Duarte, California
  • +19 more
Aug 2, 2022

Endometrial Cancer Trial in United States (Atezolizumab - 28 Day Cycle, Bevacizumab, Ipatasertib)

Recruiting
  • Endometrial Cancer
  • Atezolizumab - 28 Day Cycle
  • +6 more
  • Duarte, California
  • +13 more
Jun 8, 2022

Esophageal Squamous Cell Carcinoma Trial in Worldwide (Tiragolumab, Atezolizumab, Tiragolumab Matching Placebo)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Tiragolumab
  • +3 more
  • Corona, California
  • +223 more
Aug 3, 2022

NSCLC Trial in Worldwide (Atezolizumab, Tiragolumab, Matching Placebo)

Recruiting
  • Non-Small Cell Lung Cancer
  • Littleton, Colorado
  • +153 more
Nov 23, 2021

NSCLC (NSCLC) Trial in Worldwide (Atezolizumab, Tiragolumab, Durvalumab)

Recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • Tempe, Arizona
  • +254 more
Aug 8, 2022

Metastatic Colorectal Cancer Trial in Worldwide (Inavolisib, Bevacizumab, Cetuximab)

Recruiting
  • Metastatic Colorectal Cancer
  • Phoenix, Arizona
  • +34 more
Jul 29, 2022

Advanced Unresectable or Metastatic Solid Malignancy Trial in United States (Entrectinib, Inavolisib, Alectinib)

Recruiting
  • Advanced Unresectable or Metastatic Solid Malignancy
  • Birmingham, Alabama
  • +50 more
Aug 10, 2022